Respiratory support of patients with pneumonia in the context of the COVID-19 pandemic
DOI:
https://doi.org/10.26641/2307-0404.2024.4.319322Keywords:
artificial lung ventilation, intensive care, risks and complications, clinical scenario, new technologies and equipment, high-flow nasal oxygen therapyAbstract
The purpose of this study is to evaluate and analyse existing methods of supporting individuals suffering from pneumonia due to the coronavirus infection, as well as to find new ones. The following methods were used in a randomised controlled trial: artificial lung ventilation (ALV), non-invasive ventilation, oxygen therapy using oxygen masks and nasal cannulas, penetrating ventilation with high oxygen flow, high-flow nasal oxygen therapy; advantages and disadvantages of such methods. The analysis of a sample of 200 patients aged 18-80 years, among whom there were both women and men with different levels of severity of the disease, was carried out. The study showed that the use of penetrating ventilation with high oxygen flow significantly improves blood oxygenation and reduces the requirement for lung intubation and ALV. However, minimally invasive respiratory support and oxygen treatment have also proven to be effective methods of respiratory support. When using non-invasive ventilation and penetrating ventilation with high oxygen flow, higher survival rates and shorter hospital stay were observed in patients with pneumonia caused by coronavirus infection, compared with the use of ALV. The study revealed that the use of artificial respiration may result in more severe adverse effects, such as lung barotrauma, so it is recommended to use it only in the absence of other effective methods of respiratory support. Thus, the results of the study emphasise the need for an individual approach when choosing a method of respiratory support in patients with pneumonia caused by coronavirus infection, and also confirm the effectiveness of minimally invasive respiratory aid and high-flow oxygen penetrating ventilation in the treatment of this pathology.
References
Chandel A, Patolia S, Brown AW, Collins AC, Sahjwani D, Khangoora V, et al. High-flow nasal cannula therapy in COVID-19: Using the ROX index to predict success. Respir Care. 2021;66(6):909-19. doi: https://doi.org/10.4187/respcare.08631
Lukianchuk VD, Hordiichuk DO, Shevchuk OO. Key links in pathogenesis of respiratory failure in COVID-19 and pharmacological correction. Bulletin of Medical and Biological Research. 2022;4(2):62-74. doi: https://doi.org/10.11603/bmbr.2706-6290.2022.2.13082
Romanyuk LB, Volch I, Kravets NY, Pyatkovskyi T, Zahrychuk OM. Retrospective analysis of gender-age structure and comorbid pathology of patients with viral and bacterial pneumonia associated with COVID-19. International Journal of Medicine and Medical Research. 2021;7(2):15-9. doi: https://doi.org/10.11603/ijmmr.2413-6077.2021.2.12675
Chen L, Liu P, Gao H, Sun B, Chao D, Wang F, et al. Inhalation of nitric oxide in the treatment of severe acute respiratory syndrome: A rescue trial in Beijing. Clin Infect Dis. 2004;39(10):1531-5. doi: https://doi.org/10.1086/425357
Takeshita Y, Terada J, Hirasawa Y, Kinoshita T, Tajima H, Koshikawa K, et al. High-flow nasal cannula oxygen therapy in hypoxic patients with COVID-19 pneu¬monia: A retrospective cohort study confirming the utility of respiratory rate index. Respir Investig. 2022;60(1):146-53. doi: https://doi.org/10.1016/j.resinv.2021.10.005
Maitra S, Som A, Bhattacharjee S, Arora MK, Baidya DK. Comparison of high flow nasal oxygen therapy with conventional oxygen therapy and noninvasive mechanical ventilation in adult patients with acute hypoxemic respiratory failure: A meta-analysis and systematic review. J Crit Care. 2016;35:138-44. doi: https://doi.org/10.1016/j.jcrc.2016.05.013
Hui DS, Chow BK, Lo T, Tsang OT, Ko FW, Ng SS, et al. Exhaled air dispersion during highflow nasal cannula therapy versus CPAP via different masks. Eur Respir J. 2019;53(4):1802339. doi: https://doi.org/10.1183/13993003.02339-2018
Pasillas-Lépine W, Tuffet S, Soussen C, Mekontso-Dessap A, Carteaux G. A novel method for noninvasive estimation of respiratory effort during pressure support ventila¬tion. Biomed. Signal Process Control. 2024;93:106176. doi: https://doi.org/10.1016/j.bspc.2024.106176
Schmidt M, Hajage D, Lebreton G, Monsel A, Voiriot G, Levy D, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: A retrospective cohort study. Lancet Respir Med. 2020;8(11):1121-31. doi: https://doi.org/10.1016/S2213-2600(20)30328-3
Bertini P, Guarracino F, Falcone M, Nardelli P, Landoni G, Nocci M, et al. ECMO in COVID-19 patients: A systematic review and meta-analysis. J Cardiothorac Vasc Anesth. 2022;36(8):2700-6. doi: https://doi.org/10.1053/j.jvca.2021.11.006
Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state. JAMA. 2020;323(16):1612-4. doi: https://doi.org/10.1001/jama.2020.4326
Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, et al. COVID-19 in critically ill patients in the Seattle region – Case series. N Engl J Med. 2020;382(21):2012-22. doi: https://doi.org/10.1056/NEJMoa2004500
Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020;323(16):1574-81. doi: https://doi.org/10.1001/jama.2020.5394
Xie J, Tong Z, Guan X, Du B, Qiu H. Clinical characteristics of patients who died of coronavirus disease 2019 in China. JAMA Netw Open. 2020;3(4):e205619. doi: https://doi.org/10.1001/jamanetworkopen.2020.5619
Iwashyna TJ, Boehman A, Capecelatro J, Cohn AM, Cooke JM, Costa DK, et al. Variation in aerosol production across oxygen delivery devices in sponta¬neously breathing human subjects. medRxiv [Internet]. 2020 Apr 20 [cited 2024 Sept 11]. doi: https://doi.org/10.1101/2020.04.15.20066688
Gattinoni L, Chiumello D, Caironi P, Busana M, Romitti F, Brazzi L, et al. COVID-19 pneumonia: Dif-ferent respiratory treatments for different phenotypes? Intensive Care Med. 2020;46(6):1099-102. doi: https://doi.org/10.1007/s00134-020-06033-2
Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D. COVID-19 does not lead to a “typical” acute respiratory distress syndrome. Am J Respir Crit Care Med. 2020;201(10):1299-300. doi: https://doi.org/10.1164/rccm.202003-0817LE
Karagiannidis C, Mostert C, Hentschker C, Voshaar T, Malzahn J, Schillinger G, et al. Case characteristics, resource use, and outcomes of 10021 patients with COVID-19 admitted to 920 German hospitals: An observational study. Lancet Respir Med. 2020;8(9):853-62. doi: https://doi.org/10.1016/S2213-2600(20)30316-7
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42. doi: https://doi.org/10.1001/jama.2020.2648
Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E, et al. Surviving sepsis campaign: Gui-delines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Intensive Care Med. 2020;46(5):854-87. doi: https://doi.org/10.1007/s00134-020-06022-5
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi: https://doi.org/10.1016/S0140-6736(20)30183-5
Martinez MA. Compounds with therapeutic potential against novel respiratory 2019 coronavirus. Antimicrob Agents Chemother. 2020;64(5):e00399-20. doi: https://doi.org/10.1128/AAC.00399-20
Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res. 2020;7:4. doi: https://doi.org/10.1186/s40779-020-0233-6
Carsetti A, Paciarini AD, Marini B, Pantanetti S, Adrario E, Donati A. Prolonged prone position ventilation for SARS-CoV-2 patients is feasible and effective. Crit Care. 2020;24(1):225. doi: https://doi.org/10.1186/s13054-020-02956-w
Li L, Li R, Wu Z, Yang X, Zhao M, Liu J, et al. Therapeutic strategies for critically ill patients with COVID-19. Ann Intensive Care. 2020;10(1):45. doi: https://doi.org/10.1186/s13613-020-00661-z
Shang J, Ye G, Shi K, Wan Y, Luo C, Aihara H, et al. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020;581(7807):221-4. doi: https://doi.org/10.1038/s41586-020-2179-y
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Medicni perspektivi
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.
